Imugene Limited announced the appointment of Professor Michael Caligiuri, President of the City of Hope National Medical Center in Los Angeles, to its Scientific Advisory Board (SAB). Dr. Caligiuri is a world renowned cancer researcher and physician whose clinical work has focused on leukemia and lymphoma. Prior to his appointment at City of Hope in February of 2018, Dr. Caligiuri was The CEO of The Ohio State University (OSU), James Cancer Hospital from 2008-2017 and Director of OSU's Comprehensive Cancer Center from 2003-2017; and he had been the Director of OSU's Division of Hematology-Oncology from 2000 through 2008.